01
Research
Convene mechanistic and translational work linking radiation dose, timing and immune response.
International scientific society
Radiation is an immunological intervention.
SIRiiM is the International Society for Radiation Immunity and Immuno-Modulation. We convene the science of how ionizing radiation instructs, heightens and blunts the immune response — and we teach it to the clinicians who need it next.
02
Publication
Publish the field’s primary literature through IJRM-SSS, the Society’s flagship journal.
03
Standards
Develop consensus definitions, endpoints and reporting standards for immuno-radiation studies.
04
Education
Train primary-care and multidisciplinary partners in radiation immunity, not as a clinic brochure.
Education
What the Society teaches first
These pathways sit on siriim.org — not nested under a clinic. They adapt the education work that first appeared as Institute pages, rewritten here as Society science.
Science
Immunity
The 0.3–0.7 Gy window, the COVID lesson, and why a discontinuous dose–response is a signal, not a gradient.
ScienceAbscopal effect
Out-of-field response biology: why it is rare, what would make it reproducible, and what we will not claim.
Meeting recordASTRO 2023
How SIRiiM reads that meeting. Meeting abstracts are cited as abstracts — no invented DOI.
IndicationArthritis and LDRT
The most mature benign indication in European practice, taught here as immunomodulation, not a product page.
PathwaysPCP tutorials
Primary-care pathways: when radiation medicine belongs in the office, and when to send a partner for training.
HubFull education hub
The map of Society education, including partner training links that stay labeled as partners.
Flagship journal
International Journal of Radiation Medicine
Screening · Surveillance · Survivorship — The Orange Journal
IJRM-SSS is the peer-reviewed flagship journal of SIRiiM. It publishes original research, consensus statements and critical review across the full arc of radiation medicine. The journal lives at theorangejournal.org.
- S Screening — risk stratification, imaging strategy and immune signatures that precede clinical disease.
- S Surveillance — response assessment, residual disease and longitudinal immune monitoring.
- S Survivorship — late immune effects, second-malignancy risk and long-horizon quality of life.
Partners
Training lives next door. The Society does not.
Hands-on clinician training and primary-care practice partnership are offered by the CureRays Innovation & Education Institute and CureRays Radiation Medicine. Those CureRays Innovation & Education Institute (curerays.org) is the parent 501(c)(3). The clinic (curerays.com) is not the parent brand, and this site is not clinic chrome.
If you came from a CureRays page titled SIRiiM, you are in the right place now: the Society’s own site, at the root of siriim.org.